Abstract
RECTAL biopsy for the diagnosis of tumors of the rectum dates back at least to the beginning of this century, although it did not become a routine practice until the period between the two world wars.1 Its use in the diagnosis of amebic dysentery was reported in 1957,2 and the first attempts to define its role in the diagnosis of ulcerative colitis and Crohn's disease of the colon were also described at about that time.3 4 5 Since then interest in rectal biopsy for the diagnosis and management of inflammatory bowel disease has steadily increased.6 The introduction of fiberscopic colonoscopy has now . . .